Clinical Professor Renee Bittoun is a physiologist who is a clinical academic and a pioneer specializing in nicotine addiction for more than 40 years and is considered a world expert in the field. She is the first and only full professor of nicotine addiction in Australia. • She initiated the first ever Smokers’ Clinic in Australia in 1979, one of the first in the world and recently the first ever Vaping Cessation Clinic in Australia. • She was the founder and Editor-in-Chief of the international peer-reviewed Journal of Smoking Cessation published by Cambridge University, 2009. • She has been part of the very first Quit Campaigns of the 1980s, introduced NRT to Australia, published many articles, chapters and books on smoking cessation, nicotine addiction and now vaping. • She has been a visiting Professor at the Charles University, Prague; The Sorbonne University, Paris, Leiden University; The Netherlands, and University of Malaysia. • She is on multiple national and international committees on nicotine use and abuse amongst them, the BMJ review of nicotine treatment in mental health, and the French Cancer Society International Expert Committee. • She has worked with Australian indigenous populations for many decades, conducting clinical work in remote Aboriginal Medical Services and teaching indigenous health workers in smoking cessation. • She is currently Conjoint Clinical Professor at Notre Dame University, Australia and Professor, Head of the Nicotine Addiction Unit, Lifestyle Medicine, Avondale University, Australia. • She is in clinical practice at the Woolcock Institute of Medical Research, Macquarie University Campus. • She is an honorary Fellow of the Lifestyle Medicine Association of Australasia.

Michael Falster is an Associate Professor in the Medicines Intelligence Research Program, School of Population Health, UNSW. He is a health systems researcher and epidemiologist with expertise using population data to measure variation in quality health care. Michael leads a research program investigating real-world use of cardiometabolic medicines in Australia.

Tess Moeke-Maxwell is a descendant of Ngāi Tai ki Tāmaki and Ngāti Porou. She is a Senior Research Fellow and co-director of the Te Ārai Palliative Care and End of Life Research Group at the School of Nursing, University of Auckland. Tess leads Kaupapa Māori qualitative “lived Indigenous experience.” Improving end-of-life, palliative care and assisted dying experiences for Māori whānau (family, including extended family) are her research interests. Currently, she leads the Health Research Council (HRC) funded ‘Waerea study’ on Māori whānau experiences using Assisted Dying services and is a co-lead investigator on the (HRC) Pae Herenga, Paediatric Palliative Care study. Tess is an advisory member of the National Palliative Care Work Programme for Te Whatu Ora – Health New Zealand. In 2022, the Royal Society of NZ awarded Tess and Te Ārai Kāhui the NZ Health Research Council’s Te Tohu Rapuora Medal for research excellence with Māori communities. She was selected as one of New Zealand’s 100 Māori Leaders as part of the Henry Rongomau Bennett Foundation Leadership Strategy based on her contributions to Indigenous end-of-life care research.

Tessa Holman is a Research Officer at the Nursing Research Institute, a collaboration between St Vincent’s Health Network Sydney, St Vincent’s Hospital Melbourne, and the Australian Catholic University. Tessa holds a Bachelor of International Public Health from the University of New South Wales and has completed postgraduate study in implementation science. Her research interests include frailty, cardiovascular and end-of-life care, health equity, and translating evidence into practice within complex healthcare settings.

Dr Julee McDonagh is an RN, an NHMRC Emerging Leader Fellow, and a Senior Research Fellow in the Centre for Chronic and Complex Care Research, at the University of Wollongong and Western Sydney LHD. Dr McDonagh’s research program draws upon her clinical expertise in heart failure and coronary care, focusing on the intersection of heart failure, frailty, cardiovascular disease, aging, and multimorbidity. She is the co-lead of the ACvA Frailty and Heart Failure National Taskforce.